FMDV RNA copy numbers were significantly reduced in cells treated with 30 μM Lapatinib, indicating that inhibiting EGFR/ERBB2 tyrosine kinase activity and activation of this pathway can inhibit virus infection (Figs 6D and S5V). This evidence concerns the gene ERBB2 and viral infectious disease.